X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sun Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-17
TEVA PHARMA
Dec-13
SUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8422,685-   
Low Rs5722,333-   
Sales per share (Unadj.) Rs131.61,541.0-  
Earnings per share (Unadj.) Rs32.796.3-  
Cash flow per share (Unadj.) Rs38.0220.8-  
Dividends per share (Unadj.) Rs3.5084.27-  
Dividend yield (eoy) %0.53.4 14.7%  
Book value per share (Unadj.) Rs152.71,711.8-  
Shares outstanding (eoy) m2,399.26848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.41.6 330.1%   
Avg P/E ratio x21.626.1 83.0%  
P/CF ratio (eoy) x18.611.4 163.9%  
Price / Book Value ratio x4.61.5 316.0%  
Dividend payout %10.787.5 12.2%   
Avg Mkt Cap Rs m1,696,8772,127,522 79.8%   
No. of employees `00017.544.9 39.0%   
Total wages/salary Rs m49,0230-   
Avg. sales/employee Rs Th18,028.329,075.5 62.0%   
Avg. wages/employee Rs Th2,798.80-   
Avg. net profit/employee Rs Th4,479.51,816.3 246.6%   
INCOME DATA
Net Sales Rs m315,7841,306,800 24.2%  
Other income Rs m6,2320-   
Total revenues Rs m322,0161,306,800 24.6%   
Gross profit Rs m100,893357,868 28.2%  
Depreciation Rs m12,648105,630 12.0%   
Interest Rs m3,99825,668 15.6%   
Profit before tax Rs m90,479226,570 39.9%   
Minority Interest Rs m01,029 0.0%   
Prior Period Items Rs m990-   
Extraordinary Inc (Exp) Rs m0-148,731 0.0%   
Tax Rs m12,116-2,766 -438.0%   
Profit after tax Rs m78,46281,635 96.1%  
Gross profit margin %31.927.4 116.7%  
Effective tax rate %13.4-1.2 -1,096.8%   
Net profit margin %24.86.2 397.7%  
BALANCE SHEET DATA
Current assets Rs m329,537882,608 37.3%   
Current liabilities Rs m178,870769,708 23.2%   
Net working cap to sales %47.78.6 552.3%  
Current ratio x1.81.1 160.7%  
Inventory Days Days7991 87.0%  
Debtors Days Days8396 86.8%  
Net fixed assets Rs m204,766426,830 48.0%   
Share capital Rs m2,3993,217 74.6%   
"Free" reserves Rs m363,9970-   
Net worth Rs m366,3971,451,606 25.2%   
Long term debt Rs m14,361668,196 2.1%   
Total assets Rs m614,1022,986,456 20.6%  
Interest coverage x23.69.8 240.5%   
Debt to equity ratio x00.5 8.5%  
Sales to assets ratio x0.50.4 117.5%   
Return on assets %13.43.6 373.7%  
Return on equity %21.45.6 380.8%  
Return on capital %24.84.9 503.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m19,6340-   
CASH FLOW
From Operations Rs m70,822208,236 34.0%  
From Investments Rs m-42,216-73,787 57.2%  
From Financial Activity Rs m-22,854-249,793 9.1%  
Net Cashflow Rs m6,107-115,344 -5.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.33 Rs / USD

Compare SUN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SUN PHARMA With: ABBOTT INDIA  FDC LTD.  BIOCON LTD  SANOFI INDIA  ORCHID PHARMA LTD  



Today's Market

Share Markets in India End Flat; Dr Reddy's & Tata Steel Top Gainers(Closing)

Indian share markets continued to trade range bound in afternoon session with market participants awaiting the US Federal Reserve's policy statement.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

180,000%: The Returns That Could Have Been(The 5 Minute Wrapup)

Sep 7, 2017

For successful investing in small caps, it's important to know when not to press the panic button.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Sep 20, 2017 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - FULFORD INDIA COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS